Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanozen has developed and commercialized the DustCount family of wearable real-time personal aerosol monitors. These devices provide industrial hygienists with immediate data on mass concentration, particle concentration, and size distribution to assess worker exposure to hazardous particulates such as silica. The products are deployed globally across a range of industries for occupational health protection[2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanozen.